| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,302,600 | 2,076,400 | 2,514,600 | 2,935,900 | | Cost of Revenue | 1,158,100 | 1,760,100 | 2,068,400 | 2,284,700 | | | Gross Profit | 144,500 | 316,300 | 446,200 | 651,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 217,000 | 248,200 | 279,000 | 280,300 | | Non Recurring |
-
| 459,900 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (72,500) | (391,800) | 167,200 | 370,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,500) | (5,500) | (2,100) | 6,500 | | Earnings Before Interest And Taxes | (75,000) | (397,300) | 165,100 | 377,400 | | Interest Expense | 23,500 | 26,900 | 26,400 | 24,300 | | Income Before Tax | (98,500) | (424,200) | 138,700 | 353,100 | | Income Tax Expense | (24,000) | (2,700) | 44,900 | 116,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (74,500) | (421,500) | 93,800 | 236,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (74,500) | (421,500) | 93,800 | 236,300 | | Preferred Stock And Other Adjustments | (400) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($74,900) | ($421,500) | $93,800 | $236,300 |
|
0.45% Nasdaq 
0.20%
Income Statement
